@prefix dc1: <http://purl.org/dc/terms/> .
@prefix this: <http://purl.org/np/RAghtrnxUu54oSFtpFeJPWCSEY_H0eBuaOZ9LSK5KB2WU> .
@prefix sub: <http://purl.org/np/RAghtrnxUu54oSFtpFeJPWCSEY_H0eBuaOZ9LSK5KB2WU#> .
@prefix schema: <https://schema.org/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix nt: <https://w3id.org/np/o/ntemplate/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix orcid: <https://orcid.org/> .
@prefix bl: <https://w3id.org/biolink/vocab/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix npx: <http://purl.org/nanopub/x/> .

sub:Head {
  this: np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubinfo;
    a np:Nanopublication .
}

sub:assertion {
  <http://purl.obolibrary.org/obo/DOID_13868> bl:category bl:Disease .
  
  sub:association rdf:object <http://purl.obolibrary.org/obo/DOID_13868>;
    rdf:predicate bl:treats;
    rdf:subject <https://identifiers.org/drugbank:DB04908>;
    a rdf:Statement;
    rdfs:label "addyi r flibanserin tablets are indicated for the treatment of premenopausal women with acquired generalized hypoactive sexual desire disorder hsdd as characterized by low sexual desire that causes marked distress or interpersonal difficulty and is not due to acquired hsdd refers to hsdd that develops in a patient who previously had no problems with sexual desire generalized hsdd refers to hsdd that occurs regardless of the type of stimulation situation or partner limitations of use addyi is indicated for the treatment of premenopausal women with acquired generalized hypoactive sexual desire disorder hsdd as characterized by low sexual desire that causes marked distress or interpersonal difficulty and is not due to 1 limitations of use 1 1";
    bl:association_type bl:ChemicalToDiseaseOrPhenotypicFeatureAssociation;
    bl:provided_by <https://w3id.org/um/NeuroDKG>;
    bl:relation schema:TreatmentIndication .
  
  <https://identifiers.org/drugbank:DB04908> bl:category bl:Drug .
}

sub:provenance {
  sub:assertion prov:wasAttributedTo orcid:0000-0002-1468-3557 .
}

sub:pubinfo {
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB";
    npx:hasSignature "USB6kxPz/1AKtMivhV5brflV3pTDSokBbpYz2xBfZR4FYDAAWIQg1/MpthMb6Gv6hf1m4I2ZZIT/QN7BCyc0VnNEVzDGMILMCweH6FygwtIL49S71GsHrXxBbM5SsbE0ZFY21Kz1E4Zr02gfsg2sXjBdO5E4q7Tt2MbYXdlB/kA=";
    npx:hasSignatureTarget this: .
  
  this: dc1:created "2021-06-12T12:54:50.394+02:00"^^xsd:dateTime;
    dc1:creator orcid:0000-0002-1468-3557;
    nt:wasCreatedFromProvenanceTemplate <http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM>;
    nt:wasCreatedFromPubinfoTemplate <http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM>;
    nt:wasCreatedFromTemplate <http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs> .
}